- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07051798
- Original Trial
Phlebitis Experiences of Intensive Care Nurses
March 18, 2026 updated by: Kutahya Health Sciences University
Phlebitis Experiences of Intensive Care Nurses: A Qualitative Study
It is important to reveal the phlebitis experiences of nurses.
The data obtained from the phlebitis experiences of nurses are important in terms of preventing phlebitis and supporting patient safety practices.
In the studies conducted to date, no study has been found in the literature that qualitatively examines the phlebitis experiences of intensive care nurses.
This study is the first to be conducted in this respect, which constitutes the originality of the research.
It is expected to guide clinician and academic nurses in phlebitis assessment and phlebitis care planning and to contribute to the literature.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kütahya
-
Kütahya, Kütahya, Turkey (Türkiye), 43000
- Kutahya Health Sciences University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Intensive Care nurses
Description
Inclusion Criteria:
- Voluntarily accepting to participate in the study
- Being the primary nurse of a patient who developed phlebitis,
- Having at least 1 year of work experience.
Exclusion Criteria:
- Being assigned to the unit for a short period of time
- Being on leave or sick leave,
- Not accepting to participate in the study,
- Leaving the study during the data collection process.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Themes Identified in ICU Nurses' Experiences with Phlebitis Management
Time Frame: Within the first 2 months following the initiation of the study
|
Identification of distinct thematic categories from ICU nurses' experiences concerning the recognition, prevention, care practices, and clinical challenges related to phlebitis.
Each theme will be extracted through thematic analysis of qualitative data obtained from semi-structured interviews.
Method of Analysis: Braun & Clarke's Thematic Analysis Method Unit of Measure: Number of distinct themes identified
|
Within the first 2 months following the initiation of the study
|
|
Perceived Barriers and Facilitators in Phlebitis Management
Time Frame: Within 2 month after the completion of data collection
|
Evaluation and classification of ICU nurses' perceptions regarding institutional, educational, and individual-level factors affecting phlebitis assessment and management.
Each perceived barrier or facilitator will be categorized based on content analysis of semi-structured interview transcripts.
Method of Analysis: Content Analysis Methodology Unit of Measure: Number of identified barriers and facilitators.
|
Within 2 month after the completion of data collection
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 15, 2025
Primary Completion (Actual)
August 15, 2025
Study Completion (Actual)
March 15, 2026
Study Registration Dates
First Submitted
June 12, 2025
First Submitted That Met QC Criteria
July 2, 2025
First Posted (Actual)
July 4, 2025
Study Record Updates
Last Update Posted (Actual)
March 20, 2026
Last Update Submitted That Met QC Criteria
March 18, 2026
Last Verified
June 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KHSU20250607
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Phlebitis
-
Cukurova UniversityCompleted
-
William Beaumont HospitalsWithdrawnPeripheral Intravenous Vein Catheter Phlebitis | Intravenous InfectionUnited States
-
Corewell Health EastRecruitingPeripheral Intravenous Vein Catheter Phlebitis | Intravenous InfectionUnited States
-
University of Health Sciences LahoreNot yet recruitingPatient With IV Cannula Induce Phlebitis
-
Assistance Publique - Hôpitaux de ParisCompletedVein Infusion PhlebitisFrance
-
University of BasrahUniversity of BaghdadNot yet recruitingCancer | Chemotherapy
-
Federal University of São PauloCompleted
-
Kahramanmaras Sutcu Imam UniversityCompleted
-
Royal Brisbane and Women's HospitalUnknown
Clinical Trials on It is a qualitative type of study that will be conducted through face-to-face interviews.
-
Johnson & Johnson Consumer Inc. (J&JCI)CompletedSkin Regeneration After Dermatological Facial Procedure With Fractional CO2 LaserBrazil
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted